El 10 de febrero de 2017 el Dr. Luis Quiroga Prado (adjunto MI) repasó varios artículos:
- A placebo controlled trial of obeticholic acid in primary biliary cholangitis.
- Serious asthma events with budesonide plus formoterol vs budesonide alone.
- 10 year outcomes after monitoring, surgery or radiotherapy for localized prostate cancer.
- Patient reported outcomes after monitoring, surgery or radiotherapy for prostate cancer.
- Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double blind, placebo controlled trial (Lancet).
Su presentación se puede descargar aquí.